Loading...
Veru Community
NasdaqCM:VERU Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 17 Fair Values set on narratives written by author
Community Investing Ideas
Aging Trends And FDA Clarity Will Unlock Opportunity
Key Takeaways Innovative therapy and robust patent protection position Veru to capture strong, long-term growth in the expanding obesity and chronic disease market. Advancing clinical progress, regulatory clarity, and potential strategic partnerships could accelerate commercialization and improve earnings visibility while reducing funding risks.Read more
0users have liked this narrative
0users have commented on this narrative
13users have followed this narrative
AN
US$19.75
87.1% undervalued intrinsic discount
AnalystConsensusTarget Fair Value
Revenue growth
23.17% p.a.
Profit Margin
23.22%
Future PE
45.94x
Share price in 2028
US$22.92